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clinical practice for imaging, treatment planning and dose 
delivery. Consequently, it is necessary to verify such 
techniques and/or investigate the related dosimetric 
improvements under conditions as close as possible to the 
clinical situation. For this purpose a respiratory motion 
phantom, i.e. the Advanced Radiation Dosimetry System 
(ARDOS), was developed and a prototype was realized. This 
phantom can be used in clinical practice and research to 
verify dose delivery and image quality of lung cancer patients 
on a quantitative and reproducible basis. 
 
Material and Methods: The phantom represents an average 
human torso with a movable tumor insert and comprises a 
chest wall, ribs, and lungs (Figure 1a). These parts consist of 
tissue-equivalent materials. Different types of dosimeters can 
be inserted at the position of the tumor. The phantom’s 
movement is based on an ARDUINO microcontroller and 
dedicated software allowing to program independent 
motions: translational motion for all the parts individually, 
while the tumor additionally can be rotated. Some basic 
motion types like sinusoidal and quadratic are 
preprogrammed with the possibility of changing their 
parameters. Moreover, complex or irregular motions (e.g., 
patient-specific breathing cycles) can be reproduced. 
 
 
 
Results: To demonstrate the versatility of the phantom first a 
dosimetric investigation was performed using a clinical 
stereotactic photon beam treatment plan. The dosimetric 
study was based on ionization chamber, EBT3 film, and TL 
dosimetry. The obtained results showed differences (among 
the dosimeters) in the delivered dose between static and 
chest-wall-only or ribs-only motion of up to 1.2%. This value 
increased to 4.3% for tumor-only- and all-of-the-parts motion 
modes. In the second step real-time 2D/3D image registration 
software was verified using kV images with the moving 
tumor, chest wall and ribs in the phantom. Figure 1b shows 
results obtained from this tumor motion tracking sub-study. 
 
Conclusion: In this pilot study, the anthropomorphic 
phantom with its specific characteristics (mimicking a tumor, 
rib cage, and lungs), flexibility, and possibility to offer close-
to-real conditions was found to be easily applicable for state-
of-the-art research and QA purposes for advanced clinical 
practice. In the next steps of the project the evaluation of 
scanned ion beam radiotherapy for a moving target, as well 
as the development of a 4D QA workflow protocols, and the 
comparison of measurement data with numerical simulations 
are envisaged. 
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Purpose or Objective: MRI-guided radiotherapy is an 
emerging field of considerable interest and has prompted the 
development of specialized treatment units which integrate 
MR-imaging systems with radiation sources. Such devices 
require patients and dosimetry equipment to be immersed in 
a magnetic (B-)field. Consequently the B-field influences the 
trajectory of charged particles via the Lorentz force which 
affects the dose-distribution in water and, critically, the 
response of the ionization chambers (IC) that are needed for 
reference dosimetry. To accurately calibrate MRI-RT units it 
is necessary to correct the chamber readings for these 
effects. The purpose of this study was to validate Monte 
Carlo (MC) calculations of IC correction factors against 
measurements with and without a 1.5 T B-field in an MRI-RT 
unit. 
 
Material and Methods: Measurements were performed using 
an Elekta 1.5 T MR-linac located at The University of Texas 
MD Anderson Cancer Center with and without the B-field. An 
NE2571 Farmer chamber was placed at isocenter at depths of 
10 and 20 cm in a water-equivalent plastic phantom. Three 
orientations were examined: i) the chamber's long-axis 
parallel to the B-field; ii) the long-axis rotated 90° clockwise 
w.r.t. the B-field; and iii) the long-axis rotated 90° 
anticlockwise w.r.t. the B-field. The long-axis was always 
perpendicular to the beam. Measured charge readings were 
corrected for temperature, pressure, polarity and ion 
recombination using the TG-51 protocol. The ratios of the 
corrected readings with and without the B-field were 
compared with those predicted by a Geant4 MC model of the 
chamber with the energy spectrum from an Elekta MR-linac 
used as a source. 
 
Results: The measurements indicate that the change in 
chamber signal due to the B-field ranges from 1.4-2.5% and 
depends on the chamber orientation which compares to the 
range of 1.7-3.3% predicted by MC. The ratio of the signal 
with and without the B-field was within 0.3% of the MC values 
except for the clockwise perpendicular orientation in which a 
larger discrepancy of 2.5% was found. However, the two 
perpendicular orientations differed from each other in both 
the measured and MC data. 
 
Conclusion: Our MC calculations accurately predict the 
response of the NE2571 Farmer chamber in the 1.5 T MR-linac 
beam. Measurements performed in the parallel orientation 
are the least affected by the B-field and can be accurately 
corrected. Larger uncertainties exist for perpendicular 
orientations which are possibly due to uncertainties in the MC 
chamber geometry. 
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